Episode 25. Managing Acute Toxicities of CAR T-cell Therapy

Blood Cancer Talks

Conteúdo fornecido por Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

1+ y ago 49:08

MP3•Home de episódios

In this episode, we discuss the management of acute toxicities of CAR T-cell therapy, including CRS, ICANS, and HLH with Dr. Michael Jain from Moffitt Cancer Center.

Here are some of the key articles we discussed:

1. “How I treat refractory CRS and ICANS after CAR T-cell therapy”.

https://pubmed.ncbi.nlm.nih.gov/36989488/

2. CAR-HEMATOTOX score:

https://pubmed.ncbi.nlm.nih.gov/34166502/

3. “How I treat cytopenias after CAR T-cell therapy”.

https://pubmed.ncbi.nlm.nih.gov/36800563/

4. Immune Effector Cell-Associated HLH-Like Syndrome (ASTCT):

https://pubmed.ncbi.nlm.nih.gov/36906275/

5. ASTCT consensus grading for CRS and ICANS:

https://pubmed.ncbi.nlm.nih.gov/30592986/

6. Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy:

https://pubmed.ncbi.nlm.nih.gov/35696759/

7. Modified EASIX score for predicting CRS and neurotoxicity:

https://pubmed.ncbi.nlm.nih.gov/34432870/

52 episódios

#Fitness #Medicine #Rajshekhar Chakraborty and Ashwin Kishtagari #Ashwin Kishtagari #Rajshekhar Chakraborty #Hematology #Cancer #Podcasting Education #Edward Cliff